BP
Ben Pouladian
Compare →Founder, BEP Research · CEO, BEP Holdings · Chairman, Terasaki Institute for Biomedical Innovation
Ben Pouladian is a technology entrepreneur and investor based in Los Angeles, known for his deep expertise in AI infrastructure and semiconductor supply chains. He co-founded Deco Lighting, scaling it to over $50 million in revenue before exiting in 2019, and now leads BEP Research, where he publishes insights on AI and technology investments. He is also actively involved in angel investing and serves on the leadership board of the Terasaki Institute for Biomedical Innovation.
No chart yet. A chart needs 8 resolved predictions, and Ben has 2. The predictions themselves are below.
SORT
STILL OPEN
?
AI-designed candidates entering Phase I will show success rates of 80-90%.
Due Mar 31, 2027February 25, 2026HealthcareAIPending
—
SCORE
?
Memory prices could soften around mid-2027, before early 2028.
Due Mar 31, 2028July 14, 2026MemoryPricingPending
—
SCORE
?
The cost per approved drug will collapse below $800 million by early 2028.
Due Mar 31, 2028February 25, 2026HealthcarePharmaceuticalsPending
—
SCORE
?
Scale-up finally goes optical is more of a 2028 story.
Due Dec 31, 2028March 2026technologyopticalPending
—
SCORE
?
The DRAM/SRAM ratio will continue to impact chip architects' decisions for 2029-2030 products.
Due Dec 31, 2030January 2026semiconductorsmemory hierarchyPending
—
SCORE
?
Meta's Muse will generate most of its revenue from ads rather than subscriptions, especially in WhatsApp-first markets like India and Brazil.
September 30, 2026AIMetaPending
—
SCORE
?
FDA grants accelerated approval to the first fully AI-designed small molecule for idiopathic pulmonary fibrosis.
February 25, 2026HealthcareDrug DiscoveryPending
—
SCORE
RESOLVED · NEWEST FIRST
✓
The Token Dollar drops tomorrow
own side · their own organization · resolved, earns no score
April 3, 2026FinanceCryptocurrencyCorrect
—
SCORE
✓
xAI’s trajectory from founding in July 2023 to $230 billion valuation in December 2025 represents the fastest value creation in AI history—and it’s not done yet.
December 27, 2025call #2xAIvaluationCorrect
40
SCORE
✓
Nvidia, as an AI company, is on its way to overtaking software companies to become the largest company on Earth.
May 31, 2024call #1AISoftwareCorrect
63
SCORE
Still open · 7
THE FRONT EDGENot resolved, so they don’t move the score.
?No market prices this claim
AI-designed candidates entering Phase I will show success rates of 80-90%.
Due Mar 31, 2027Said February 25, 2026HealthcareAI
?No market prices this claim
Memory prices could soften around mid-2027, before early 2028.
Due Mar 31, 2028Said July 14, 2026MemoryPricing
?No market prices this claim
The cost per approved drug will collapse below $800 million by early 2028.
Due Mar 31, 2028Said February 25, 2026HealthcarePharmaceuticals
?No market prices this claim
Scale-up finally goes optical is more of a 2028 story.
Due Dec 31, 2028Said March 2026technologyoptical
?No market prices this claim
The DRAM/SRAM ratio will continue to impact chip architects' decisions for 2029-2030 products.
Due Dec 31, 2030Said January 2026semiconductorsmemory hierarchy
?No market prices this claim
Meta's Muse will generate most of its revenue from ads rather than subscriptions, especially in WhatsApp-first markets like India and Brazil.
Said September 30, 2026AIMeta
?No market prices this claim
FDA grants accelerated approval to the first fully AI-designed small molecule for idiopathic pulmonary fibrosis.
Said February 25, 2026HealthcareDrug Discovery